The cancer glyco-genomic code
Cancer cells radically alter their cell surface glycans during tumour development. Cancer-associated glycan structures often act as signals that shut off immune activity, helping cancer cells hide from the immune system.
The Wisnovsky lab is using CRISPR knockout (CRISPR KO) and CRISPR interference (CRISPRi) screening techniques to identify the molecular pathways in cancer cells that drive these fundamental changes in cellular glycosylation. We expect our work to identify new cancer-specific vulnerabilities that can be targeted for tumour immunotherapy.

Wisnovsky Lab